Paper96243
Tissue tropism of different Trypanosoma cruzi strains.
Melo RC and 1 other. J Parasitol, 1978. Cited by 236 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Tissue tropism of different Trypanosoma cruzi strains. Papers, record 96243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/96243
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chagas Disease | Major topic |
| Species Specificity | Major topic |
| Trypanosoma cruzi | Major topic |
| Animals | |
| Erythrocytes | |
| Guinea Pigs | |
| Heart | |
| Humans | |
| Intestines | |
| Liver | |
| Male | |
| Muscle, Smooth | |
| Muscles | |
| Spleen | |
| Stomach |
Source PubMed
Cited by89
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 236 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41599090 | Kinetics of Biomarkers for Therapeutic Assessment in Swiss Mice Infected with a Virulent Trypanosoma cruzi Strain. | Pathogens | 2026 | https://conductscience.org/library/papers/41599090 | PubMed |
| 40661785 | Apoptosis: A Key Process That Trypanosoma cruzi Modulates as a Strategy to Perpetuate Infection. | J Parasitol Res | 2025 | https://conductscience.org/library/papers/40661785 | PubMed |
| 40318604 | Efficacy of benznidazole delivery during Chagas disease nanotherapy is dependent on the nanocarrier morphology. | Biomaterials | 2025 | https://conductscience.org/library/papers/40318604 | PubMed |
| 40116484 | Coinfection by multiple Trypanosoma cruzi clones: a new perspective on host-parasite relationship with consequences for pathogenesis and management of Chagas disease. | Microbiol Mol Biol Rev | 2025 | https://conductscience.org/library/papers/40116484 | PubMed |
| 38905323 | Dynamics of Trypanosoma cruzi infection in hamsters and novel association with progressive motor dysfunction. | PLoS Negl Trop Dis | 2024 | https://conductscience.org/library/papers/38905323 | PubMed |
| 38672758 | The End Justifies the Means: Chagas Disease from a Perspective of the Host-Trypanosoma cruzi Interaction. | Life (Basel) | 2024 | https://conductscience.org/library/papers/38672758 | PubMed |
| 38655255 | New insights into Trypanosoma cruzi genetic diversity, and its influence on parasite biology and clinical outcomes. | Front Immunol | 2024 | https://conductscience.org/library/papers/38655255 | PubMed |
| 38304823 | A versatile 2A peptide-based strategy for ectopic expression and endogenous gene tagging in Trypanosoma cruzi. | Heliyon | 2024 | https://conductscience.org/library/papers/38304823 | PubMed |
| 37033490 | Protective effects of Theracurmin treatment during experimental infection of the Colombian strain of Trypanosoma cruzi at the testicular site. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/37033490 | PubMed |
| 36986434 | Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/36986434 | PubMed |
| 35909611 | Biological features of TcM: A new Trypanosoma cruzi isolate from Argentina classified into TcV lineage. | Curr Res Microb Sci | 2022 | https://conductscience.org/library/papers/35909611 | PubMed |
| 35154155 | C57BL/6 Mice Pretreated With Alpha-Tocopherol Show a Better Outcome of Trypanosoma cruzi Infection With Less Tissue Inflammation and Fibrosis. | Front Immunol | 2022 | https://conductscience.org/library/papers/35154155 | PubMed |
| 35069009 | The Colombian Strain of Trypanosoma cruzi Induces a Proinflammatory Profile, Neuronal Death, and Collagen Deposition in the Intestine of C57BL/6 Mice Both during the Acute and Early Chronic Phase. | Mediators Inflamm | 2022 | https://conductscience.org/library/papers/35069009 | PubMed |
| 34222391 | Epidemiology of Trypanosomiasis in Wildlife-Implications for Humans at the Wildlife Interface in Africa. | Front Vet Sci | 2021 | https://conductscience.org/library/papers/34222391 | PubMed |
| 34207764 | Benznidazole Treatment: Time- and Dose-Dependence Varies with the Trypanosoma cruzi Strain. | Pathogens | 2021 | https://conductscience.org/library/papers/34207764 | PubMed |
| 33133034 | Dynamics of Mammalian Cell Infection by Trypanosoma cruzi trypomastigotes. | Front Microbiol | 2020 | https://conductscience.org/library/papers/33133034 | PubMed |
| 32985548 | Motility patterns of Trypanosoma cruzi trypomastigotes correlate with the efficiency of parasite invasion in vitro. | Sci Rep | 2020 | https://conductscience.org/library/papers/32985548 | PubMed |
| 32799361 | Host-parasite dynamics in Chagas disease from systemic to hyper-local scales. | Parasite Immunol | 2021 | https://conductscience.org/library/papers/32799361 | PubMed |
| 32591392 | Cutting Edge: Augmenting Muscle MHC Expression Enhances Systemic Pathogen Control at the Expense of T Cell Exhaustion. | J Immunol | 2020 | https://conductscience.org/library/papers/32591392 | PubMed |
| 32175284 | Modulatory Effect of Trypanosoma cruzi Infective Stages in Different Dendritic Cell Populations in vitro. | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/32175284 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/96243
GET https://conductscience.org/api/papers/v1/96243/cited_by?page=2